PHARMACOGNOSY II

Course's Contribution to Prog.

0 : Doesn’t support 1 : Low-level support 2 : Mid-level support 3 : High-level support

No	Program Qualifications	Level of Contribution
		0	1	2	3
1	A) SOCIAL COMPETENCIES (S1-S8)\nS1: Constantly learns: Knows the development of the pharmacy profession from past to present and directs current practices in this direction. A pharmacist who can continue profession throughout life is committed to lifelong learning and is constructive in this regard. A lifelong career also requires lifelong learning. The pharmacist keeps his knowledge and skills up to date.	X
2	S2: Teaches: It provides new knowledge to pharmacists, the public, healthcare personnel and the next generation of pharmacists. Helps healthcare personnel and the next generation of pharmacists by training them to gain new knowledge as well as improve their existing skills.	X
3	S3: Researches and practices profession based on evidence: Carries out medicine and health consultancy by sharing his experiences, optimizing and based on evidence. The research pharmacist is impartial. Provides impartial and accurate information to the public and healthcare personnel and increases accessibility.	X
4	S4: Communicates effectively: The pharmacist, who is in touch with the society and acts as an important bridge between the doctor and the patient, uses communication techniques, information, media and technology effectively to respond to written and verbal communication from various audiences for different purposes.	X
5	S5: Decides: Pharmacist, effective cost utilization, analysis in daily studies, research, problem solving in product and patient-oriented service regarding drug/medical device/cosmetic/herbal medical product, personnel, equipment, legislation and application resources, Makes appropriate, objective, effective and ethical decisions with synthesis skills.	X
6	S6: Provides leadership: In situations and regions that require multidisciplinary care and/or where the personnel responsible for providing healthcare services is inadequate, the pharmacist assumes the role of leader in the welfare of the patient and the society. In addition to being reliable, consistent, compassionate and empathetic as a leader, also has decision-making, effective communication and effective management skills. Solution oriented.	X
7	S7: A team player and practices her profession with team spirit: The pharmacist cooperates with colleagues, has a professional personality, high values, principles and working behavior and respect.	X
8	S8: An entrepreneur and active manager: While practicing profession, the pharmacist identifies material and human resource requirements and uses resources and information appropriately, effectively and creatively. Develops new ideas and approaches to improve the profession, increase quality or overcome obstacles.	X
9	B) TECHNICAL COMPETENCIES (T1-T110). Competency Levels (L1-L4): L1=Has knowledge of how the application is done and gives guidance. L2=Performs the application with resources/guide/instructions or with help. L3=Performs without assistance in general applications. L4=Does alone in complex situations.\nT1: Uses thin layer chromatography (TLC) method in drug analysis (L3).	X
10	T2: Uses column chromatography method in drug analysis (L2)	X
11	T3: Evaluates gas chromatography (GC) data in drug analysis (L2).	X
12	T4: It uses high pressure liquid chromatography (HPLC) method in drug analysis (L2).	X
13	T5: Uses electrochemical methods in drug analysis (D2).	X
14	T6: Uses ultraviolet (UV) spectrophotometric method in drug analysis (L2).	X
15	T7: Uses infrared (IR) spectrophotometric method in drug analysis (L2).	X
16	T8: Evaluates nuclear magnetic resonance (NMR) spectrometric method data in drug analysis (L2).	X
17	T9: Evaluates mass spectroscopy method data in drug analysis (L2).	X
18	T10: Conducts characterization analyzes of active pharmaceutical ingredients/excipients (L2).	X
19	T11: Uses qualitative methods in drug analysis (L2).	X
20	T12: Uses quantitative methods in drug analysis (L2).	X
21	T13: Develops analytical method (L2).	X
22	T14: Evaluates the stages of developing new drug substances (L1).	X
23	T15: Synthesizes the active drug (L2).	X
24	T16: Clarifies the structure of the active pharmaceutical ingredient (L2).	X
25	T17: Evaluates the metabolism of the active drug substance (L3).	X
26	T18: Obtains active substance/excipient from natural sources (L2).	X
27	T19: Develops active substance/excipient from natural sources (L1).	X
28	T20: Identifies medicinal, poisonous or narcotic plants (L2).	X
29	T21: Performs quality control on natural resources (L2).	X
30	T22: Prepares traditional herbal medicinal products (L3).	X
31	T23: Defines homeopathic products (L1).	X
32	T24: Provides consultancy on traditional herbal medicinal products (L3).	X
33	T25: Prepares medicinal teas and advises on medicinal teas (L3).	X
34	T26: Performs pharmaceutical calculation (L4).	X
35	T27: Improves drug formulation (L3).	X
36	T28: Performs pre-formulation work (L3).	X
37	T29: Designs solid dosage forms (L2).	X
38	T30: Designs semi-solid dosage forms (L2).	X
39	T31: Designs liquid dosage forms (L2).	X
40	T32: Designs aerosol dosage forms (L1).	X
41	T33: Designs drug carrier systems (L2).	X
42	T34: Produces drug carrier systems (L2).	X
43	T35: Designs cosmetic/cosmeceutical products (L2).	X
44	T36: Prepares Cosmetics/Cosmeceutical products (L2).	X
45	T37: Detects and evaluates chemical incompatibility between drugs (L2).	X
46	T38: Conducts stability studies (L2).	X
47	T39: Performs raw material/semi-finished/finished product quality control for pharmaceutical/medical device/cosmetic products (L3).	X
48	T40: Controls microbial contamination in pharmaceuticals/medical devices/cosmetics/herbal medicinal products (L2).	X
49	T41: Evaluates production stages at pilot scale (L1).	X
50	T42: Conducts product improvement studies (L2).	X
51	T43: Performs biotechnological and biosimilar product production and analysis (L2).	X
52	T44: Conducts the stages of preparing radiopharmaceutical products and presenting them to the patient (L2).	X
53	T45: Conducts the preparation and presentation stages of biotechnological products (L2).	X
54	T46: Provides biosimilar drugs to the patient (L2).	X
55	T47: Provides decontamination, disinfection, sterilization and antisepsis conditions (L3).	X
56	T48: Prepares medicine under aseptic conditions (L4).	X
57	T49: Prepares antineoplastic drugs in the hospital (L3).	X
58	T50: Prepares the magistral preparation (L4).	X
59	T51: Provides medical device consultancy (L2).	X
60	T52: Takes the patient\'s medication history (L4).	X
61	T53: Provides medicine and health consultancy for central nervous system diseases (L2).	X
62	T54: Provides medicine and health consultancy for musculoskeletal system diseases (L2).	X
63	T55: Provides medicine and health consultancy for circulatory system diseases (L2).	X
64	T56: Provides medicine and health consultancy in hematopoietic diseases (L2).	X
65	T57: Provides medicine and health consultancy for respiratory system diseases (L2).	X
66	T58: Provides medicine and health consultancy in endocrine system diseases (L2).	X
67	T59: Provides medicine and health consultancy in immune system diseases (L2).	X
68	T60: Provides medicine and health consultancy for gastrointestinal system diseases (L2).	X
69	T61: Provides medicine and health consultancy for urinary system diseases (L2).	X
70	T62: Provides medicine and health consultancy for genital diseases (L2).	X
71	T63: Provides medicine and health consultancy in dermatological diseases (L2).	X
72	T64: Provides medicine and health consultancy in oncological diseases (L2).	X
73	T65: Provides medicine and health consultancy in infectious diseases (L2).	X
74	T66: Informs patients and relevant healthcare personnel about rational and safe drug use in chronic diseases (L3).	X
75	T67: Informs patients and relevant healthcare personnel about rational and safe drug use in special patient groups (L3).	X
76	T68: Informs the patient about the rational and safe use of medical devices used in chronic diseases (L4).	X
77	T69: Provides consultancy on the rational and safe use of food supplements (L3).	X
78	T70: Evaluates the safety of veterinary drugs (L2).	X
79	T71: Detects and evaluates drug-drug/nutrient/natural product/disease interactions (L3).	X
80	T72: Controls the doses of medications (L4).	X
81	T73: Detects and evaluates side/adverse effects of medications (L3).	X
82	T74: Evaluates the toxic effects of drugs (L2).	X
83	T75: Applies the principles of rational drug use (L4).	X
84	T76: Creates a patient profile and monitors the medication treatment process (L4).	X
85	T77: Monitors and evaluates patient compliance throughout treatment (L3).	X
86	T78: Provides pharmaceutical care/Clinical pharmacy services (L3).	X
87	T79: Evaluates diagnostic tests and interprets laboratory findings (L2).	X
88	T80: Monitors and interprets drug blood levels (L2).	X
89	T81: Evaluates the toxic consequences of non-drug xenobiotics (L2).	X
90	T82: Performs pharmacy practices based on scientific evidence (L4).	X
91	T83: Conducts bioavailability/Bioequivalence studies (L2).	X
92	T84: Prepares, dispenses and records prescription and non-prescription medications to the patient (L4).	X
93	T85: Provides and administers specialty prescription medications (L4).	X
94	T86: Participates in pharmacovigilance practice (L4).	X
95	T87: Follows first aid instructions (L2).	X
96	T88: Takes part in preclinical drug research (L1).	X
97	T89: Participates in clinical drug research (L2).	X
98	T90: Prepares drug license file (L2).	X
99	T91: Conducts drug-related patent screening and evaluation studies (L1).	X
100	T92: Contributes to cost minimization in drug expenditures by providing bioequivalents where appropriate (L3).	X
101	T93: Evaluates regulations, laws and policies regarding health and medicine (L3).	X
102	T94: Manages the storage, stocking, distribution and disposal processes of pharmaceuticals/medical devices/cosmetics/herbal medicinal products (L4).	X
103	T95: Uses information management systems in pharmacy (L4).	X
104	T96: Operates and manages the pharmacy (L4).	X
105	T97: Manages finances (L2).	X
106	T98: Evaluates the methods required for pharmacoeconomic analysis (L2).	X
107	T99: Develops marketing strategy (L2).	X
108	T100: Uses effective communication knowledge and skills (L4).	X
109	T101: Applies ethical principles and rules (L4).	X
110	T102: Uses knowledge about the historical development of the pharmacy profession when necessary (L3).	X
111	T103: Uses leadership principles in professional practices (L4).	X
112	T104: Uses knowledge of entrepreneurship education (L2).	X
113	T105: Evaluates common symptoms and makes necessary referrals (L3).	X
114	T106: Directs forensic cases and psychosocial situations to the physician or relevant institution (L2).	X
115	T107: Provides healthy life consultancy within the framework of their professional competence (L3).	X
116	T108: Provides consultancy in public health-related situations (L2).	X
117	T109: Analyzes biochemical parameters in biological samples (D2).	X
118	T110: Provides consultancy on herbal products used in phytotherapy (D3).	X